Ironwood Pharmaceuticals Inc (IRWD)

Number of records: 50
SEC FilingInsiderCompanyTrade DateTransactionSharesAvg. PriceTotal% HoldingsReturn
19-Mar-24 4:05 PM
View: 
Denner Alexander J
Director
10% Owner
Ironwood Pharmaceuticals Inc (IRWD) 15-Mar-24Grant 1,662----< 1%
16.51M to 16.51M
12-Mar-24 4:05 PM
View: 
McCourt Thomas A
Chief Executive Officer
Director
Ironwood Pharmaceuticals Inc (IRWD) 08-Mar-24Option Exercise 120,298----11%
1.1M to 1.22M
12-Mar-24 4:05 PM
View: 
John Minardo
Chief Legal Officer
Ironwood Pharmaceuticals Inc (IRWD) 08-Mar-24Option Exercise 32,752----12%
279.22K to 311.98K
12-Mar-24 4:05 PM
View: 
Davis Andrew
SVP, Chief Business Officer
Ironwood Pharmaceuticals Inc (IRWD) 08-Mar-24Option Exercise 37,120----14%
273.64K to 310.76K
12-Mar-24 4:05 PM
View: 
Shetzline Michael
CMO,SVP,Head-Res&Drug
Ironwood Pharmaceuticals Inc (IRWD) 08-Mar-24Option Exercise 34,936----9%
394.91K to 429.85K
12-Mar-24 4:05 PM
View: 
Emany Sravan Kumar
SVP, Chief Financial Officer
Ironwood Pharmaceuticals Inc (IRWD) 08-Mar-24Option Exercise 37,120----12%
301.73K to 338.85K
08-Mar-24 4:05 PM
View: 
Duane Jon R
Director
Ironwood Pharmaceuticals Inc (IRWD) 06-Mar-24Private Purchase 6,920$8.70$60,204.006%
114.11K to 121.03K
07-Mar-24 4:05 PM
View: 
McCourt Thomas A
Chief Executive Officer
Director
Ironwood Pharmaceuticals Inc (IRWD) 05-Mar-24Grant 264,876----32%
832.77K to 1.1M
06-Mar-24 4:05 PM
View: 
Emany Sravan Kumar
SVP, Chief Financial Officer
Ironwood Pharmaceuticals Inc (IRWD) 04-Mar-24Private Purchase 10,684$9.38$100,216.004%
291.05K to 301.73K
14-Feb-24 8:42 PM
View: 
Davis Andrew
SVP, Chief Business Officer
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Sale 9,846$15.24$150,053.00(3%)
283.48K to 273.64K
14-Feb-24 8:53 PM
View: 
Shetzline Michael
CMO,SVP,Head-Res&Drug
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Sale 38,618$15.24$588,538.00(9%)
433.53K to 394.91K
14-Feb-24 8:50 PM
View: 
Silver Ronald
Principal Accounting Officer
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Grant 27,213----19%
142.17K to 169.38K
14-Feb-24 8:35 PM
View: 
McCourt Thomas A
Chief Executive Officer
Director
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Private Sale 177,164$15.24$2,699,980.00(18%)
1.01M to 832.77K
14-Feb-24 8:50 PM
View: 
Silver Ronald
Principal Accounting Officer
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Sale 7,908$15.24$120,518.00(5%)
169.38K to 161.48K
14-Feb-24 9:01 PM
View: 
John Minardo
Chief Legal Officer
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Grant 54,427----20%
272.18K to 326.6K
14-Feb-24 8:42 PM
View: 
Davis Andrew
SVP, Chief Business Officer
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Grant 65,312----30%
218.17K to 283.48K
14-Feb-24 8:53 PM
View: 
Shetzline Michael
CMO,SVP,Head-Res&Drug
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Grant 54,427----14%
379.1K to 433.53K
14-Feb-24 8:39 PM
View: 
Emany Sravan Kumar
SVP, Chief Financial Officer
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Grant 65,312----29%
225.74K to 291.05K
14-Feb-24 9:01 PM
View: 
John Minardo
Chief Legal Officer
Ironwood Pharmaceuticals Inc (IRWD) 12-Feb-24Sale 47,380$15.24$722,071.00(15%)
326.6K to 279.22K
12-Feb-24 4:05 PM
View: 
Emany Sravan Kumar
SVP, Chief Financial Officer
Ironwood Pharmaceuticals Inc (IRWD) 08-Feb-24Payment of Exercise 41,332$14.90$615,847.00(15%)
267.07K to 225.74K
19-Jan-24 4:05 PM
View: 
McCourt Thomas A
Chief Executive Officer
Director
Ironwood Pharmaceuticals Inc (IRWD) 17-Jan-24Grant 249,617----33%
760.32K to 1.01M
19-Jan-24 4:05 PM
View: 
John Minardo
Chief Legal Officer
Ironwood Pharmaceuticals Inc (IRWD) 17-Jan-24Grant 79,981----42%
192.19K to 272.18K
19-Jan-24 4:05 PM
View: 
Shetzline Michael
CMO,SVP,Head-Res&Drug
Ironwood Pharmaceuticals Inc (IRWD) 17-Jan-24Grant 57,971----18%
321.13K to 379.1K
19-Jan-24 4:05 PM
View: 
Emany Sravan Kumar
SVP, Chief Financial Officer
Ironwood Pharmaceuticals Inc (IRWD) 17-Jan-24Grant 85,000----47%
182.07K to 267.07K
19-Dec-23 4:05 PM
View: 
Denner Alexander J
Director
10% Owner
Ironwood Pharmaceuticals Inc (IRWD) 15-Dec-23Grant 1,347----< 1%
16.51M to 16.51M
19-Dec-23 4:05 PM
View: 
Moukheibir Catherine
Director
Ironwood Pharmaceuticals Inc (IRWD) 15-Dec-23Grant 1,572----1%
127.06K to 128.63K
18-Dec-23 4:09 PM
View: 
Kessler Marla L
Director
Ironwood Pharmaceuticals Inc (IRWD) 14-Dec-23Market Sale (Planned) 9,926$11.19$111,072.00(9%)
106.5K to 96.57K
(6%)
22-Nov-23 4:05 PM
View: 
Davis Andrew
SVP, Chief Business Officer
Ironwood Pharmaceuticals Inc (IRWD) 20-Nov-23Sale 3,287$9.69$31,851.00(1%)
220.66K to 217.37K
20-Nov-23 4:05 PM
View: 
Emany Sravan Kumar
SVP, Chief Financial Officer
Ironwood Pharmaceuticals Inc (IRWD) 16-Nov-23Payment of Exercise 6,661$9.44$62,879.80(4%)
188.73K to 182.07K
19-Sep-23 5:05 PM
View: 
Moukheibir Catherine
Director
Ironwood Pharmaceuticals Inc (IRWD) 15-Sep-23Grant 2,098----2%
124.96K to 127.06K
19-Sep-23 5:04 PM
View: 
Denner Alexander J
Director
10% Owner
Ironwood Pharmaceuticals Inc (IRWD) 15-Sep-23Grant 1,798----< 1%
16.51M to 16.51M
18-Sep-23 5:07 PM
View: 
Emany Sravan Kumar
SVP, Chief Financial Officer
Ironwood Pharmaceuticals Inc (IRWD) 15-Sep-23Private Purchase 36,072$8.32$300,119.0024%
152.66K to 188.73K
31-Aug-23 4:05 PM
View: 
Silver Ronald
Principal Accounting Officer
Ironwood Pharmaceuticals Inc (IRWD) 29-Aug-23Grant 8,000----6%
134.17K to 142.17K
16-Aug-23 4:21 PM
View: 
Silver Ronald
Principal Accounting Officer
Ironwood Pharmaceuticals Inc (IRWD) 14-Aug-23Sale 1,976$10.04$19,839.00(1%)
136.15K to 134.17K
16-Aug-23 4:20 PM
View: 
John Minardo
Chief Legal Officer
Ironwood Pharmaceuticals Inc (IRWD) 14-Aug-23Sale 7,045$10.04$70,731.80(4%)
199.24K to 192.19K
22-Jun-23 5:29 PM
View: 
McHugh Julie
Director
Ironwood Pharmaceuticals Inc (IRWD) 20-Jun-23Grant 22,350----16%
139.94K to 162.29K
22-Jun-23 5:30 PM
View: 
Moukheibir Catherine
Director
Ironwood Pharmaceuticals Inc (IRWD) 20-Jun-23Grant 22,350----22%
102.61K to 124.96K
22-Jun-23 5:31 PM
View: 
Shepard Jay
Director
Ironwood Pharmaceuticals Inc (IRWD) 20-Jun-23Grant 22,350----28%
79.89K to 102.24K
22-Jun-23 5:29 PM
View: 
Kessler Marla L
Director
Ironwood Pharmaceuticals Inc (IRWD) 20-Jun-23Grant 22,350----27%
84.15K to 106.5K
22-Jun-23 5:26 PM
View: 
Denner Alexander J
Director
10% Owner
Ironwood Pharmaceuticals Inc (IRWD) 20-Jun-23Grant 22,350----< 1%
16.48M to 16.51M
22-Jun-23 5:26 PM
View: 
Currie Mark G
Director
Ironwood Pharmaceuticals Inc (IRWD) 20-Jun-23Grant 22,350----4%
521.76K to 544.11K
22-Jun-23 5:28 PM
View: 
Duane Jon R
Director
Ironwood Pharmaceuticals Inc (IRWD) 20-Jun-23Grant 22,350----24%
91.76K to 114.11K
22-Jun-23 5:27 PM
View: 
Dreyfus Andrew
Director
Ironwood Pharmaceuticals Inc (IRWD) 20-Jun-23Grant 22,350----15%
146.63K to 168.98K
20-Jun-23 4:05 PM
View: 
Denner Alexander J
Director
10% Owner
Ironwood Pharmaceuticals Inc (IRWD) 15-Jun-23Grant 1,359----< 1%
16.48M to 16.48M
20-Jun-23 4:05 PM
View: 
Moukheibir Catherine
Director
Ironwood Pharmaceuticals Inc (IRWD) 15-Jun-23Grant 1,586----2%
101.03K to 102.61K
01-Jun-23 5:45 PM
View: 
McCourt Thomas A
Chief Executive Officer
Director
Ironwood Pharmaceuticals Inc (IRWD) 30-May-23Market Sale (Planned) 26,632$10.70$284,962.00(3%)
784.92K to 758.28K
(11%)
24-May-23 10:00 PM
View: 
Davis Andrew
SVP, Chief Business Officer
Ironwood Pharmaceuticals Inc (IRWD) 22-May-23Sale 6,305$10.12$63,806.60(3%)
225.63K to 219.33K
24-May-23 4:05 PM
View: 
Shetzline Michael
CMO,SVP,Head-Res&Drug
Ironwood Pharmaceuticals Inc (IRWD) 22-May-23Sale 10,324$10.12$104,479.00(3%)
331.45K to 321.13K
24-May-23 10:00 PM
View: 
McCourt Thomas A
Chief Executive Officer
Director
Ironwood Pharmaceuticals Inc (IRWD) 22-May-23Sale 36,000$10.12$364,320.00(4%)
820.92K to 784.92K
10-May-23 4:05 PM
View: 
McCourt Thomas A
Chief Executive Officer
Director
Ironwood Pharmaceuticals Inc (IRWD) 08-May-23Market Sale (Planned) 21,148$10.62$224,592.00(3%)
842.06K to 820.92K
(12%)